GemCap Biotech ApS
Nøgletal
- Afkastningsgrad
- –
- Egenkapitalforrentning
- 0 %
- Likviditetsgrad
- –
- Soliditetsgrad
- 100 %
Højdepunkter fra årsrapporten
Forretning og udvikling
The Company's Principal Activitie
Welcome to our 2018 Annual Report. The companys purpose is to conduct development, production, financing, investmentbusiness and trade.
In 2018, there has been no activity.
Development in activities and the financial situation
The Company's Income Statement of the financial year 1 January 2023 - 31 December 2023 shows a result of DKK and the Balance Sheet at 31 December 2023 a balance sheet total of DKK 27.000 and an equity of DKK 27.000.…
Development in the activities and the financial situation of the Company
Post Balance Sheet Events…
Forpligtelser og sikkerhedsstillelser
The Group's Danish companies are jointly and severally liable for tax on the Group's jointly taxed income, etc. The total amount of corporation tax payable is stated in the annual report of GemCap APS, which is a management company in relation to joint taxation. The Group's Danish companies are jointly and severally liable for Danish taxes in the form of income tax, royalties and interest tax. Any subsequent corrections to corporation tax and other taxes may result in the company's liability amounting to a larger amount.
No other contingent liabilities exist at the balance sheet date.
4. Collaterals and securities
No securities or mortgages exist at the balance sheet date.
Se op til 9 års regnskabshistorik ved at oprette en gratis bruger
Opret gratis bruger